Calithera Biosciences, Inc. Gains 55.65%
Mon, Jan 31, 2022 at 05:30 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) jumped higher at $0.65, representing a gain of 55.7%. On Fri, Jan 28, 2022, CALA:NASDAQ hit a New 2-Week Intraday Low of $0.4. The stock got featured on our News Catalysts scanner on Wed, Jan 05, 2022 at 08:49 PM in the 'MISCELLANEOUS' category. From Fri, Jan 14, 2022, the stock recorded 22.22% Up Days and 20.00% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- Calithera Biosciences, Inc. (CALA:NASDAQ), 55.65%
- Inspira Technologies Oxy B.H.N. Ltd. (IINN:NASDAQ), 36.52%
- Vaccinex, Inc. (VCNX:NASDAQ), 33.63%
- Bassett Furniture Industries, Incorporated (BSET:NASDAQ), 33.14%
- Knightscope Inc. (KSCP:NASDAQ), 31.37%
- FGI Industries Ltd. (FGI:NASDAQ), 28.91%
- Provention Bio, Inc. (PRVB:NASDAQ), 28.85%
- Astria Therapeutics Inc. (ATXS:NASDAQ), 27.48%
- Cognition Therapeutics Inc. (CGTX:NASDAQ), 26.8%
- Romeo Power Inc. Class A (RMO:NYSE), 25.53%